Article Details

Nurix Therapeutics (NASDAQ:NRIX) Stock Rating Upgraded by Zacks Investment Research

Retrieved on: 2021-06-10 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Nurix Therapeutics (NASDAQ:NRIX) Stock Rating Upgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 239,935 shares of the company's stock valued at $7,460,000 after buying an additional 126,731 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up